{
    "nct_id": "NCT03348956",
    "official_title": "Biomarkers in Chemotherapy-Induced Peripheral Neurotoxicity: Better Tools and Understanding",
    "inclusion_criteria": "* Scheduled to receive chemotherapy with taxane compounds for the treatment of breast cancer.\n* No prior taxane or platinum chemotherapy prior to enrollment.\n* Life expectancy greater than or equal to 12 months.\n* Able to provide independent informed consent for the study.\n* Able to undergo EPR oximetry\n* Age 18 years or older\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Central nervous system or other impairments that interfere with clinical and electrophysiological assessment.\n* Unable to provide independent informed consent.\n* Pacemaker or other metallic objects that would be contraindicated for MRI.\n* A requirement for supplemental oxygen at baseline, or known, severe chronic obstructive pulmonary disease .\n* Previous exposure to neurotoxic chemotherapeutic agents.",
    "miscellaneous_criteria": ""
}